Literature DB >> 11212430

Cancer chemotherapy during pregnancy. Consortium of cancer in pregnancy evidence.

M Lishner1, G Koren.   

Abstract

QUESTION: I have an 8-weeks' pregnant patient who was diagnosed with stage III Hodgkin's disease last week. The oncologist suggests delaying chemotherapy until the second trimester. What are the effects of chemotherapy on a fetus after the first trimester? Where can I find reliable information on the subject? ANSWER: Available data suggest that exposure to chemotherapy during the first trimester of pregnancy is associated with increased risk of major malformations. Exposure during the second and third trimesters does not result in major malformations, but could have nonteratogenic effects, such as low birth weight. The brain develops throughout pregnancy, and it could be affected later in pregnancy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11212430      PMCID: PMC2014699     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  14 in total

1.  Effects of cancer chemotherapeutic agents on the human fetus.

Authors:  J E SOKAL; E M LESSMANN
Journal:  J Am Med Assoc       Date:  1960-04-16

2.  Growth and development of children of mothers treated with chemotherapy during pregnancy: current status of 43 children.

Authors:  A Avilés; J C Díaz-Maqueo; A Talavera; R Guzmán; E L García
Journal:  Am J Hematol       Date:  1991-04       Impact factor: 10.047

3.  Excretion of platinum into breast milk.

Authors:  E G de Vries; A G van der Zee; D R Uges; D T Sleijfer
Journal:  Lancet       Date:  1989-03-04       Impact factor: 79.321

Review 4.  Cytotoxic drugs in pregnancy. Review of reported cases.

Authors:  H O Nicholson
Journal:  J Obstet Gynaecol Br Commonw       Date:  1968-03

5.  Treatment of neoplastic disease during pregnancy: maternal and fetal effects.

Authors:  S B Sutcliffe
Journal:  Clin Invest Med       Date:  1985       Impact factor: 0.825

Review 6.  Management of cancer during pregnancy.

Authors:  D C Doll; Q S Ringenberg; J W Yarbro
Journal:  Arch Intern Med       Date:  1988-09

7.  Fetal outcome after in utero exposure to cancer chemotherapy.

Authors:  D Zemlickis; M Lishner; P Degendorfer; T Panzarella; S B Sutcliffe; G Koren
Journal:  Arch Intern Med       Date:  1992-03

8.  Teratogenicity and carcinogenicity in a twin exposed in utero to cyclophosphamide.

Authors:  D Zemlickis; M Lishner; R Erlich; G Koren
Journal:  Teratog Carcinog Mutagen       Date:  1993

9.  Pregnancy outcome following cancer chemotherapy.

Authors:  J Blatt; J J Mulvihill; J L Ziegler; R C Young; D G Poplack
Journal:  Am J Med       Date:  1980-12       Impact factor: 4.965

10.  Doxorubicin and cisplatin excretion into human milk.

Authors:  P C Egan; M E Costanza; P Dodion; M J Egorin; N R Bachur
Journal:  Cancer Treat Rep       Date:  1985-12
View more
  2 in total

1.  Acute lymphoblastic leukemia during gestation.

Authors:  Charis Matsouka; Spyridon Marinopoulos; Despina Barbaroussi; Aris Antsaklis
Journal:  Med Oncol       Date:  2007-11-27       Impact factor: 3.064

2.  Clinical characteristics and outcome of cancer diagnosed during pregnancy.

Authors:  Min Hee Shim; Chi-Won Mok; Kylie Hae-Jin Chang; Ji-Hee Sung; Suk-Joo Choi; Soo-Young Oh; Cheong-Rae Roh; Jong-Hwa Kim
Journal:  Obstet Gynecol Sci       Date:  2016-01-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.